rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Gland Pharma Ltd.

543245 GLAND Group (A)

22 Jul,15:29
1997.30
4.95 (0.25%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Gland Pharma Ltd.

BUYSELL

8,738 1,992.35 2,007.30 - 1,958.75 2,195.75 - 1,172.05 32,915.51
NSE | BSE

Gland Pharma Ltd.

GLAND

22 Jul,15:48
1994.75
4.15 (0.21%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Gland Pharma Ltd.

BUYSELL

82,892 1990.60 2,009.00 - 1,961.10 2,194.00 - 1,190.00 165,299,910.72

News for Gland Pharma Ltd.

KKR Acquires Baby Memorial Hospital for Rs 2k cr
Global PE major KKR acquires a controlling stake in Kerala-based Baby Memorial Hospital for Rs 2,000 crore, aiming to expand its healthcare network in India.
Jul 01, 2024 20:01
Fosun Sells 6%...
Fosun Sells 6% Stake in Gland Pharma for Rs 1,754 Crore
Fosun Pharma has divested a 6% stake in Gland Pharma for Rs 1,754 crore through an open market transaction, reducing its shareholding to 51.86%. UBS Principal Capital Asia acquired a 0.5% stake.
Jun 19, 2024 21:50
Gland Pharma Q4 Profit Surges to Rs 192 cr
Gland Pharma's consolidated profit after tax (PAT) jumped over two-fold to Rs 192 crore in the March quarter, driven by strong revenue growth. The company also announced a final dividend of Rs 20...
May 22, 2024 19:40
Gland Pharma Gets...
Gland Pharma Gets USFDA Approval for Generic Edaravone Injection
Gland Pharma receives USFDA approval for its generic Edaravone injection, used to treat amyotrophic lateral sclerosis (ALS). The company expects to launch the product through its marketing partner...
May 07, 2024 12:56
KKR Acquires...
KKR Acquires Healthium Medtech for Rs 7,000 Cr
KKR has acquired medical device firm Healthium Medtech from Apax Partners for up to Rs 7,000 crore. The deal marks KKR's latest investment in the healthcare sector in India and the Asia Pacific.
May 06, 2024 20:33

More News for Gland Pharma Ltd. »

(Rs. Crore)

Financial Results of Gland Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales4,167.433,616.534,400.713,462.882,633.24
Operating profit1,408.781,018.551,510.641,302.27955.47
Interest7.847.415.243.417.18
Gross profit1,567.601,251.601,729.341,433.631,087.45
EPS (Rs)63.3447.1173.7860.9549.88

See more in Research Center »

News for Pharmaceuticals and health care

Suzlon Group Q1...
Suzlon Group Q1 Profit Soars 300%, Revenue Rises
Suzlon Group's Q1 PAT nearly tripled to Rs 302 crore on strong revenue growth. The company also boasts a record order book of 3.8 GW. Read more.
Jul 22, 2024 21:36
Mental Health...
Mental Health Crisis in India: Experts Urge Action
Experts highlight the unaddressed mental health crisis in India, calling for increased accessibility to resources, awareness, and a paradigm shift to tackle the issue.
Jul 22, 2024 21:34
Nagpur Leads...
Nagpur Leads Maharashtra in Solar Rooftop Panels | MSEDCL
Nagpur district boasts the highest solar rooftop panel installations in Maharashtra, accounting for 17.28% of the state's total, according to MSEDCL. Learn about the scheme and its benefits.
Jul 22, 2024 21:30
Gensol Wins Bid...
Gensol Wins Bid for 116 MW Solar Projects in Gujarat
Gensol Engineering wins bid for 116 MW solar projects in Gujarat, distributed across 27 locations under Paschim Gujarat Vij Co. Ltd. (PGVCL).
Jul 22, 2024 20:50
Parandur Airport...
Parandur Airport Gets Site Clearance: Tamil Nadu
The Union government has granted site clearance for the proposed Parandur airport in Tamil Nadu, a key development for the state's aviation sector. The project will be implemented by the Tamil Nadu...
Jul 22, 2024 20:49

More News »

Top News

Suzlon Group Q1...
Suzlon Group Q1 Profit Soars 300%, Revenue Rises
Suzlon Group's Q1 PAT nearly tripled to Rs 302 crore on strong revenue growth. The company also boasts a record order book of 3.8 GW. Read more.
Jul 22, 2024 21:36
Mental Health...
Mental Health Crisis in India: Experts Urge Action
Experts highlight the unaddressed mental health crisis in India, calling for increased accessibility to resources, awareness, and a paradigm shift to tackle the issue.
Jul 22, 2024 21:34
Nagpur Leads...
Nagpur Leads Maharashtra in Solar Rooftop Panels | MSEDCL
Nagpur district boasts the highest solar rooftop panel installations in Maharashtra, accounting for 17.28% of the state's total, according to MSEDCL. Learn about the scheme and its benefits.
Jul 22, 2024 21:30
SAD Appeals for...
SAD Appeals for Tax Devolution Formula Change to 16th Finance Commission
Shiromani Akali Dal (SAD) urges the 16th Finance Commission to modify the tax devolution formula, increase central funds for Punjab, and address issues like crop diversification, farmer debt, and...
Jul 22, 2024 21:29
Private Sector...
Private Sector Investment to Improve: CEA
India's Chief Economic Advisor expects private sector investment to further improve in the coming months, driven by government capex and a potential uptick in Chinese FDI.
Jul 22, 2024 21:18

More Top News »

Report Card

PE Ratios
31.45
EPS (Rs.)
63.34
Sales (Rs. Cr)
1,174.83
Face Value (Rs.)
1
Net Profit Margin (%)
21.45
Last Bonus
Last Dividend(%)
2000
Return on Average Equity
9.75

Compare 'Gland Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Gland Pharma Ltd. performance snapshot

If you had invested Rs.  in Gland Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add Gland Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Gland Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close